StocksMedium•1 October 2026•
1 min read
Liquidia Shares Fall After Patent Ruling Favoring United Therapeutics
Key Facts
1Liquidia Corporation shares plunged 57% following a court ruling in favor of United Therapeutics regarding patent infringement.
2The ruling threatens the commercial indication for Liquidia's Yutrepia (PH-ILD) and creates significant uncertainty for its outlook.
Liquidia shares fell after a court ruling in a patent dispute favored United Therapeutics, according to Zacks. Zacks said the ruling concerned patent infringement and affected Liquidia.
The ruling threatens the commercial indication for Yutrepia in PH-ILD and adds uncertainty to Liquidia’s outlook, Zacks reported. LQDA closed at $30.26 on September 30, 2026.